Concur Pharmaceuticals Private Limited, a active private limited company, was established on 14 March 2011 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100DL2011PTC215797. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 61 professional, Its leadership includes Amrit Kaushal (Director), Patanjali Kumar (Director), Ajeet Kumar (Director). Past directors included Amrit Kaushal, Nikhil Kumar Jha, Ravi Rai. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office Space No F7&F8,1St Floor, St.Soldier Tower Plot No. 3&4 Community Center, G Block,, Vikaspuri, Delhi, Delhi, 110018.
U24100DL2011PTC215797
215797
14 March 2011
₹1.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Concur Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amrit Kaushal | Director | 16 Jan 2012 | Current |
| Patanjali Kumar | Director | 16 Jan 2012 | Current |
| Ajeet Kumar | Director | 14 Mar 2011 | Current |
| Sandip Hazari | Director | 05 Mar 2012 | Current |
| Ravi Shankar Choudhary | Director | 05 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 27 Mar 2018 | Past |
| Pramod Abcsdd | Director | 15 Feb 2014 | Past |
| Pramod Abcsdd | Additional Director | 27 Mar 2018 | Past |
| Pramod Abcsdd | Managing Director | 03 Apr 2016 | Past |
| Pramod Abcsdd | Additional Director | 27 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Concur Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.34% increase. The company also saw a substantial improvement in profitability, with a 13.2% increase in profit. The company's net worth Soared by an impressive increase of 16.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Concur Pharmaceuticals had a public holding of 76.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Concur Pharmaceuticals has a workforce of 61 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Concur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concur Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Concur Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Concur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Sandip Hazari was appointed as a Director was appointed as a Director on 05 Mar 2012 & has been associated with this company since 13 years 8 months . was recorded as a recent event.
The activity Ravi Shankar Choudhary was appointed as a Director was appointed as a Director on 05 Mar 2012 & has been associated with this company since 13 years 8 months . was completed.
The activity Amrit Kaushal was appointed as a Director was appointed as a Director on 16 Jan 2012 & has been associated with this company since 13 years 10 months . was completed.
The activity Patanjali Kumar was appointed as a Director was appointed as a Director on 16 Jan 2012 & has been associated with this company since 13 years 10 months . was completed.
The CIN of Concur Pharmaceuticals Private Limited is U24100DL2011PTC215797.
Concur Pharmaceuticals Private Limited is headquartered at Office Space No F7&F8,1St Floor, St.Soldier Tower Plot No. 3&4 Community Center, G Block,, Vikaspuri, Delhi, Delhi, 110018.
Concur Pharmaceuticals Private Limited was incorporated on 14 March 2011.
The current directors of Concur Pharmaceuticals Private Limited are
The primary industry of Concur Pharmaceuticals Private Limited is Trade.
Concur Pharmaceuticals Private Limited is unlisted.
The authorized capital of Concur Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Concur Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX